BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 23, 2017
View Archived Issues
Galapagos initiates phase I trial of cystic fibrosis C2 corrector GLPG-3221
Read More
First subject dosed in phase III study of Nevakar's ophthalmic solution for myopia in children
Read More
Novel COMT inhibitors as candidates for dopaminergic-related cognitive and motor deficits
Read More
BTRX-335140, a potent and reversible KOR antagonist with promising in vivo activity
Read More
LDN/OSU-215111 shows promise in preclinical models of Alzheimer's disease and Gulf War illness
Read More
Beactica receives funding to develop novel and potent allosteric LSD1 modulators
Read More
Supplemental NDA seeks to expand Trelegy Ellipta label in U.S.
Read More
Prometic Life Sciences reports interim data from IVIG phase III trial
Read More
Teijin's TEI-A reduces uric acid levels in preclinical tests
Read More
Rupafin set for Japanese launch
Read More
Shionogi & Co. patents new AMPK activators for diabetes
Read More
Phase II trials of milciclib in thymic carcinoma and thymoma meet primary endpoints
Read More
Bavencio launched in Japan
Read More
Perrigo completes divestiture of API business
Read More
Innate Pharma offers update on lirilumab program
Read More
Sage Therapeutics discloses novel NMDA receptor modulators
Read More
Shenogen Pharma and Lee's Pharm collaborate to develop combination product for late-stage cancer
Read More
Fochon Pharma presents novel CDK4/6 inhibitors
Read More
DSMB recommends continuation of RESOLVE-IT study of elafibranor in NASH
Read More
Immunovaccine discloses vaccine compositions for cancer
Read More
European Commission approves Tremfya
Read More
New vasopressin receptor antagonists presented by Bayer
Read More